Skip to main content

Table 1 Characteristics of study participants according to the weighted vitamin D genetic risk score (GRScombined) stratified by gender (n = 10655)

From: Association of 25-hydroxyvitamin D with cardiometabolic risk factors and metabolic syndrome: a mendelian randomization study

Characteristic

GRScombined

P for trend

Quartile 1

Quartile 2

Quartile 3

Quartile 4

Men

 GRScombined

≤2.480

2.481–3.520

3.521–4.640

≥4.641

 

 N

1072

1066

995

952

 

 Age, yr

55.5 (13.2)

55.5 (13.2)

55.7 (13.1)

55.8 (13.0)

0.547

 25(OH)D, mmol/L

45.3 (14.1)

44.0 (13.3)

42.7 (13.6)

41.5 (12.7)

< 0.001

 Fasting plasma glucose, mmol/L

5.67 (1.43)

5.72 (1.54)

5.76 (1.63)

5.87 (1.81)

0.005

 Body mass index, kg/m2

25.0 (3.4)

24.9 (3.4)

25.0 (3.6)

25.0 (3.5)

0.719

 Waist circumference, cm

85.1 (9.9)

85.2 (9.2)

85.1 (9.5)

85.3 (9.5)

0.714

 Triglycerides, mmol/L

1.85 (1.93)

1.85 (1.95)

1.91 (1.93)

1.91 (1.60)

0.345

 High-density lipoprotein, mmol/L

1.32 (0.32)

1.33 (0.32)

1.33 (0.33)

1.31 (0.31)

0.566

 Systolic blood pressure, mmHg

135 (21)

134 (20)

135 (21)

134 (21)

0.731

 Diastolic blood pressure, mmHg

82 (13)

82 (13)

82 (13)

82 (13)

0.224

 Current smoker, %

44.1

44.7

45.2

46.9

0.712

 Central obesity, %

31.8

32.6

32.1

33.2

0.579

 Raised fasting plasma glucose, %

36.6

38.1

39.8

42.0

0.006

 Raised triglycerides, %

42.1

44.4

43.9

42.9

0.796

 Reduced high-density lipoprotein, %

25.3

26.0

26.3

28.4

0.105

 Raised blood pressure, %

67.8

68.9

68.6

65.7

0.286

 Metabolic syndrome, %

21.9

25.0

24.4

23.7

0.416

 Rural/urban residence, %

49.3/50.7

49.2/50.8

49.7/50.3

48.9/51.1

0.936

 Low/high econmic status, %

33.9/66.1

34.2/65.8

35.7/64.3

36.7/63.3

0.129

Women

 GRScombined

≤2.440

2.441–3.480

3.481–4.640

≥4.641

 

 N

1601

1189

1493

1418

 

 Age, yr

54.0 (12.8)

54.4 (12.9)

54.5 (12.8)

54.7 (12.3)

0.120

 Premenopausal women, %

47.7

47.4

46.1

45.3

0.161

 25(OH)D, mmol/L

40.3 (12.5)

38.5 (11.9)

38.7 (12.1)

37.4 (11.2)

< 0.001

 Fasting plasma glucose, mmol/L

5.58 (1.43)

5.62 (1.43)

5.61 (1.46)

5.57 (1.32)

0.868

 Body mass index, kg/m2

24.3 (3.6)

24.5 (3.5)

24.4 (3.7)

24.4 (3.7)

0.668

 Waist circumference, cm

78.3 (9.8)

78.9 (9.8)

78.6 (10.1)

78.5 (9.6)

0.592

 Triglycerides, mmol/L

1.52 (1.05)

1.59 (1.18)

1.48 (1.06)

1.55 (1.07)

0.985

 High-density lipoprotein, mmol/L

1.44 (0.31)

1.45 (0.31)

1.47 (0.32)

1.45 (0.32)

0.238

 Systolic blood pressure, mmHg

131 (22)

132 (21)

131 (22)

132 (22)

0.258

 Diastolic blood pressure, mmHg

77 (13)

78 (13)

78 (13)

78 (13)

0.424

 Current smoker, %

1.9

2.0

2.5

2.0

0.487

 Central obesity, %

43.8

46.5

45.2

47.0

0.150

 Raised fasting plasma glucose, %

33.4

35.4

33.8

34.1

0.892

 Raised triglycerides, %

36.1

36.3

31.3

35.7

0.244

 Reduced high-density lipoprotein, %

39.8

38.0

34.6

38.1

0.110

 Raised blood pressure, %

56.6

58.9

56.0

57.7

0.905

 Metabolic syndrome, %

30.0

32.4

29.8

31.2

0.809

 Rural/urban residence, %

44.9/55.1

45.8/54.2

47.2/52.8

46.9/53.1

0.193

 Low/high econmic status, %

32.5/67.5

31.7/68.3

32.4/67.6

32.5/67.5

0.910

  1. The data are summarized as the mean (SD) for continuous variables or as a numerical proportion for categorical variables. P for trend was calculated by ANOVA and chi-square tests. 25(OH)D, 25-hydroxyvitamin D; GRS, genetic risk score